Zdravka Medarova

4.9k total citations · 1 hit paper
86 papers, 3.9k citations indexed

About

Zdravka Medarova is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zdravka Medarova has authored 86 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 22 papers in Cancer Research and 20 papers in Surgery. Recurrent topics in Zdravka Medarova's work include RNA Interference and Gene Delivery (23 papers), MicroRNA in disease regulation (20 papers) and Pancreatic function and diabetes (20 papers). Zdravka Medarova is often cited by papers focused on RNA Interference and Gene Delivery (23 papers), MicroRNA in disease regulation (20 papers) and Pancreatic function and diabetes (20 papers). Zdravka Medarova collaborates with scholars based in United States, Canada and Australia. Zdravka Medarova's co-authors include Anna Moore, Guangping Dai, Wellington Pham, Mehmet V. Yigit, Victoria Petkova, Christian T. Farrar, Pamela Pantazopoulos, Natalia V. Evgenov, Susan Bonner‐Weir and Byunghee Yoo and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Zdravka Medarova

84 papers receiving 3.9k citations

Hit Papers

In vivo imaging of siRNA delivery and silencing in tumors 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In vivo imaging of siRNA delivery and silencing in tumors
    2007 524 citations Zdravka Medarova, Wellington Pham et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zdravka Medarova United States 32 1.7k 966 866 707 558 86 3.9k
Anna Moore United States 40 2.5k 1.4× 1.7k 1.8× 1.4k 1.6× 1.1k 1.5× 1.0k 1.8× 123 6.9k
Shinae Kizaka‐Kondoh Japan 35 2.3k 1.3× 934 1.0× 315 0.4× 195 0.3× 324 0.6× 110 4.4k
Chong-xian Pan United States 31 1.7k 1.0× 797 0.8× 329 0.4× 614 0.9× 257 0.5× 104 4.2k
Paul M.J. McSheehy Switzerland 31 2.2k 1.3× 470 0.5× 374 0.4× 203 0.3× 281 0.5× 77 4.4k
James P. Basilion United States 38 2.2k 1.3× 1.7k 1.8× 1.1k 1.2× 154 0.2× 900 1.6× 84 5.3k
Mary A. Napier United States 29 1.8k 1.1× 471 0.5× 575 0.7× 207 0.3× 223 0.4× 44 3.9k
Andrew I. Minchinton Canada 30 2.0k 1.2× 1.4k 1.5× 824 1.0× 275 0.4× 255 0.5× 103 5.1k
Zhanhong Wu United States 29 855 0.5× 664 0.7× 253 0.3× 301 0.4× 473 0.8× 79 3.1k
Hoe Suk Kim South Korea 25 1.4k 0.8× 800 0.8× 705 0.8× 179 0.3× 781 1.4× 61 3.0k
Wanyi Tai United States 23 1.8k 1.0× 926 1.0× 847 1.0× 130 0.2× 307 0.6× 47 3.0k

Countries citing papers authored by Zdravka Medarova

Since Specialization
Citations

This map shows the geographic impact of Zdravka Medarova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdravka Medarova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdravka Medarova more than expected).

Fields of papers citing papers by Zdravka Medarova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdravka Medarova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdravka Medarova. The network helps show where Zdravka Medarova may publish in the future.

Co-authorship network of co-authors of Zdravka Medarova

This figure shows the co-authorship network connecting the top 25 collaborators of Zdravka Medarova. A scholar is included among the top collaborators of Zdravka Medarova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdravka Medarova. Zdravka Medarova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kenyon, Elizabeth, et al.. (2025). Nanotherapy Targeting miR-10b Improves Survival in Orthotopic Glioblastoma Models. Journal of Functional Biomaterials. 17(1). 15–15.
2.
Varkaris, Andreas & Zdravka Medarova. (2024). 383P Clinical experience with TTX-MC138: A first-in-class therapy against metastatic cancer. Annals of Oncology. 35. S379–S379. 2 indexed citations
3.
Kenyon, Elizabeth, et al.. (2024). Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties. Oncotarget. 15(1). 591–606. 8 indexed citations
4.
Yoo, Byunghee, Alana Ross, Pamela Pantazopoulos, & Zdravka Medarova. (2021). MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer. Scientific Reports. 11(1). 2844–2844. 16 indexed citations
5.
Medarova, Zdravka, et al.. (2021). Role of microRNAs in glioblastoma. Oncotarget. 12(17). 1707–1723. 54 indexed citations
6.
Yoo, Byunghee, Patricia Greninger, Giovanna T. Stein, et al.. (2018). Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin. PLoS ONE. 13(7). e0201046–e0201046. 13 indexed citations
7.
Yoo, Byunghee, Amol Kavishwar, Ping Wang, et al.. (2017). Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Scientific Reports. 7(1). 45060–45060. 37 indexed citations
8.
Yoo, Byunghee, Amol Kavishwar, Alana Ross, et al.. (2015). Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer Research. 75(20). 4407–4415. 65 indexed citations
9.
Medarova, Zdravka, Mustafa Balcioglu, & Mehmet V. Yigit. (2015). Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging. Methods in molecular biology. 1372. 163–179. 11 indexed citations
10.
Yigit, Mehmet V., Subrata Ghosh, Zdravka Medarova, & Anna Moore. (2012). Abstract 2952: Image-guided miRNA therapy for metastatic breast cancer. Cancer Research. 72(8_Supplement). 2952–2952. 2 indexed citations
11.
Ghosh, Subrata, Pamela Pantazopoulos, Zdravka Medarova, & Anna Moore. (2012). Expression of Underglycosylated MUC1 Antigen in Cancerous and Adjacent Normal Breast Tissues. Clinical Breast Cancer. 13(2). 109–118. 34 indexed citations
12.
Medarova, Zdravka, Dale L. Greiner, Marytheresa A. Ifediba, et al.. (2011). Imaging the pancreatic vasculature in diabetes models. Diabetes/Metabolism Research and Reviews. 27(8). 767–772. 12 indexed citations
13.
Ghosh, Subrata, Pilhan Kim, Xiaoan Zhang, et al.. (2010). A Novel Imaging Approach for Early Detection of Prostate Cancer Based on Endogenous Zinc Sensing. Cancer Research. 70(15). 6119–6127. 99 indexed citations
14.
Kumar, Mohanraja, Mehmet V. Yigit, Guangping Dai, Anna Moore, & Zdravka Medarova. (2010). Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug. Cancer Research. 70(19). 7553–7561. 127 indexed citations
15.
Medarova, Zdravka & Anna Moore. (2009). MRI as a tool to monitor islet transplantation. Nature Reviews Endocrinology. 5(8). 444–452. 50 indexed citations
16.
Pham, Wellington, Bing–Qiao Zhao, Eng H. Lo, et al.. (2005). Crossing the blood–brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging. NeuroImage. 28(1). 287–292. 59 indexed citations
17.
Evgenov, Natalia V., Zdravka Medarova, Guangping Dai, Susan Bonner‐Weir, & Anna Moore. (2005). In vivo imaging of islet transplantation. Nature Medicine. 12(1). 144–148. 214 indexed citations
18.
Moore, Anna, Zdravka Medarova, Andreas Potthast, & Guangping Dai. (2004). In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe. Cancer Research. 64(5). 1821–1827. 170 indexed citations
19.
Medarova, Zdravka, et al.. (2003). Resistance, susceptibility, and immunity to cecal coccidiosis: effects of B complex and alloantigen system L. Poultry Science. 82(7). 1113–1117. 2 indexed citations
20.
Medarova, Zdravka, W. Elwood Briles, & Robert L. Taylor. (2002). Alloantigen System L Affects the Outcome of Rous Sarcomas1. Experimental Biology and Medicine. 227(3). 158–163. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Moore Breakdown of academic impact, for papers by Shinae Kizaka‐Kondoh Breakdown of academic impact, for papers by Chong-xian Pan Breakdown of academic impact, for papers by Paul M.J. McSheehy Breakdown of academic impact, for papers by James P. Basilion Breakdown of academic impact, for papers by Mary A. Napier Breakdown of academic impact, for papers by Andrew I. Minchinton Breakdown of academic impact, for papers by Zhanhong Wu Breakdown of academic impact, for papers by Hoe Suk Kim Breakdown of academic impact, for papers by Wanyi Tai
Rankless by CCL
2026